Coronavirus vaccine: India begins world’s largest drive


However issues have been raised over the efficacy of Covaxin as a result of the

regulator’s emergency approval came before the completion of Phase 3 clinical trials. The regulator and the producer have stated the vaccine is secure, and that the efficacy information can be accessible by February.